| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/06/1993 | US5225199 Multilayer bandages of polyester films and adhesives |
| 07/06/1993 | US5225198 Drug delivery |
| 07/06/1993 | US5225197 Pharmaceutical formulation |
| 07/06/1993 | US5225196 Bioadhesive compositions and methods of treatment therewith |
| 07/06/1993 | US5225192 Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate |
| 07/06/1993 | US5225189 Gelation by specific mixing sequence of carbomer, water, alcohol, amine, and glycol |
| 07/06/1993 | US5225183 Medicinal aerosol formulations |
| 07/06/1993 | US5224989 Film-forming dispersion for a protective coating of drug and food containing articles and objects |
| 07/06/1993 | US5224493 Spermicides of metal oxide salt imbedded in excipient and securing in cervix |
| 07/06/1993 | CA1319888C Process for the preparation of an antipsoriatic pharmaceutical composition |
| 07/06/1993 | CA1319886C Mixed micelle solutions |
| 07/01/1993 | CA2086492A1 Medicinal aerosol formulation |
| 07/01/1993 | CA2086442A1 N-acyl derivatives of aminoalcohols active as local autocoidis and useful in the therapy of autoimmune processes |
| 07/01/1993 | CA2086441A1 N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having meuroimmunogenic origin |
| 07/01/1993 | CA2086348A1 2-saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 07/01/1993 | CA2086346A1 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 06/30/1993 | EP0549420A1 Dry, porous galenic form made of plants, method to prepare it and its applications |
| 06/30/1993 | EP0549331A1 Controlled release drug dispersion delivery device |
| 06/30/1993 | EP0549281A1 Dentinal desensitizing compositions |
| 06/30/1993 | EP0549267A1 Lip treatment composition |
| 06/30/1993 | EP0548794A2 Polyaspartamide derivative as adsorbent for bile acids, polyaspartamide loaded with bile acids and preparation and use as a drug |
| 06/30/1993 | EP0548635A1 Pharmaceutical compositions of roxindol or carmoxirol with pregelatinized starch |
| 06/30/1993 | EP0548601A1 Process for rapid thawing and storage of frozen fluorocarbon emulsion, and resultant product |
| 06/30/1993 | EP0548595A2 Pharmaceutical system for the administration of controlled release therapeutically active dihydropyridines, and method to produce it |
| 06/30/1993 | EP0548558A2 Compositions containing surfactants as potentiating agents for the treatment of mammalian diseases |
| 06/30/1993 | EP0548448A1 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 06/30/1993 | EP0548344A1 Collagen composites for controlled drug release |
| 06/30/1993 | EP0548238A1 Non-aqueous liquid oral suspensions |
| 06/30/1993 | EP0548210A1 Liposomes |
| 06/30/1993 | EP0548145A1 Topical treatment and composition |
| 06/30/1993 | EP0548123A1 Anti-inflammatory factor, method of isolation, and use |
| 06/30/1993 | EP0548088A1 Method of producing semi-solid preparations containing micro-particulate substances |
| 06/30/1993 | EP0542864A4 Treatment for hypercholesterolemia |
| 06/30/1993 | EP0455631B1 Preparation containing salicylic acid for treating desquamative skin diseases |
| 06/30/1993 | EP0442968A4 Self-foaming oil compositions and process for making and using same |
| 06/30/1993 | EP0404807B1 Deprenyl for systemic transdermal administration |
| 06/29/1993 | US5223515 Injectable solution containing a pyridyl methylsulfinylbenzimidazole |
| 06/29/1993 | US5223510 Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation and compositions containing them |
| 06/29/1993 | US5223504 Xanthine compounds and compositions, and methods of using them |
| 06/29/1993 | US5223271 Lithium treatment |
| 06/29/1993 | US5223268 Improved bioavailability |
| 06/29/1993 | US5223267 Analgesic compositions |
| 06/29/1993 | US5223266 Long-term delivery device with early startup |
| 06/29/1993 | US5223265 Delivery, expansion chambers with osmagents, osmapolymers |
| 06/29/1993 | US5223264 Pediatric effervescent dosage form |
| 06/29/1993 | US5223263 Viricide complex; aids therapy |
| 06/29/1993 | US5223262 Transdermal delivery system utilizing one way membranes |
| 06/29/1993 | US5223261 Transdermal estradiol delivery system |
| 06/29/1993 | US5223260 Flavoring, fragrance, skin texturizing and deodorant materials and method of making same |
| 06/29/1993 | US5223259 Lollipop for sucking; preventing swallowing, choking large pieces; children, older patients |
| 06/29/1993 | US5223251 Containing microporous cellulse powder |
| 06/29/1993 | US5223246 Powdered mixture of antibacterial oxo-carboxylic acids having fused nitrogen rings, carbonates, water soluble binders, for treatment of drinking water for livestock |
| 06/29/1993 | CA1319616C Long-acting diclofenac sodium preparation |
| 06/29/1993 | CA1319615C Method of preparing a solid composition of lactulose, and composition so obtained |
| 06/29/1993 | CA1319614C Delivery vehicles with amphiphile-associated active ingredient |
| 06/29/1993 | CA1319608C Electrolytic transdermal delivery of proteins |
| 06/29/1993 | CA1319468C Polymer blends having reverse phase morphology for controlled delivery of bioactive agents |
| 06/25/1993 | CA2085711A1 Process for rapid thawing and storage of frozen fluorocarbon emulsion, and resultant product |
| 06/24/1993 | WO1993012251A1 Senescent cell derived inhibitors of dna synthesis |
| 06/24/1993 | WO1993012240A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | WO1993011868A1 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them |
| 06/24/1993 | WO1993011844A1 A method for coated particles in a spray-drying plant |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | WO1993011788A1 Gonadotropin containing pharmaceutical compositions with sucrose stabilizer |
| 06/24/1993 | WO1993011785A1 Stabilized parathyroid hormone composition |
| 06/24/1993 | WO1993011775A1 Transdermal azidothymidine |
| 06/24/1993 | WO1993011773A1 New combination of formoterol and budesonide |
| 06/24/1993 | WO1993011754A1 Cetylpyridinium chloride and domiphen bromide in organic solvent |
| 06/24/1993 | WO1993011752A1 Defoaming composition |
| 06/24/1993 | WO1993011750A1 Ulcer prevention and treatment composition and method |
| 06/24/1993 | WO1993011749A1 A process for the preparation of a solid dispersion |
| 06/24/1993 | WO1993011748A1 Oral osmotic device |
| 06/24/1993 | WO1993011747A1 Suspension aerosol formulations |
| 06/24/1993 | WO1993011746A1 Inhalation powders and method of manufacturing them |
| 06/24/1993 | WO1993011745A1 Medicaments |
| 06/24/1993 | WO1993011744A1 Medicaments |
| 06/24/1993 | WO1993011743A1 Medicaments |
| 06/24/1993 | WO1993011736A1 Hair spray aerosol system |
| 06/24/1993 | WO1993011735A1 Treatment of fungal infections |
| 06/24/1993 | WO1993010163A3 Adhesive hydrogels having extended use lives and process for the preparation of same |
| 06/24/1993 | WO1993009762A3 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 06/24/1993 | DE4241128A1 Transdermal aspirin dosage forms - for antithrombotic therapy or cancer prophylaxis |
| 06/24/1993 | CA2654849A1 Fluorocarbon aerosol medicaments |
| 06/24/1993 | CA2356145A1 New combination of formoterol and budesonide |
| 06/24/1993 | CA2126101A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | CA2125980A1 A method for coating particles in a spray-drying plant |
| 06/24/1993 | CA2125483A1 Cetylpyridinium chloride and domiphen bromide in organic solvent |
| 06/24/1993 | CA2122585A1 Transdermal azidothymidine |
| 06/23/1993 | WO1993011757A1 Drug formulations for parenteral use |
| 06/23/1993 | EP0547688A1 Sustained release tablets |
| 06/23/1993 | EP0547654A1 Contrast agents for ultrasound imaging |
| 06/23/1993 | EP0547523A1 Ethanolates of 6-sulfonylsubstituted 3-hydroxychromanes and their use as inhalation means for illnesses |
| 06/23/1993 | EP0547422A2 Stable powdery vitamin and/or carotinoid preparations and process for their production |
| 06/23/1993 | EP0547294A1 Pharmaceutical compositions containing rifaximin for treatment of vaginal infections |
| 06/23/1993 | EP0547229A1 External preparation containing cyclosporin |
| 06/23/1993 | EP0547203A1 In vivo delivery of active factors by co-cultured cell implants. |
| 06/23/1993 | EP0528978A4 Controlled release dopamine and its use to stimulate nerve fiber growth |
| 06/23/1993 | EP0432243B1 Method for direct production of nanocapsules |
| 06/23/1993 | EP0348527B1 Antiallergic eye drop |
| 06/23/1993 | CN1073358A Improved freeze drying isocyclophosphamide composite |